MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-20-0031057
Rendis Pharma India Private Limited
Rendis Pharma India Private Limited - food and beverages in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹83.51 Lakh
▲ 7% YoY
Net profit · FY 2024
₹1.35 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹2.98 Lakh
EBITDA margin 3.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Rendis Pharma India Private Limited
Data last updated:
Rendis Pharma India Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 11 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304PB2018PTC047738. Its GSTIN is 03AAICR8814Q1ZS (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjit Singh and Kamaljeet.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Singhpura Road Near Parsuram Mandir Kurali, Mohali, Punjab, India – 140103.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.51 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.35 Lakh (net margin 1.6%) and EBITDA of ₹2.98 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years.
Rendis Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0031057).
Company details
CIN U24304PB2018PTC047738
Registration Number 047738
Incorporation Date 11 April 2018
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0031057
Key People
Ranjit Singh Director Kamaljeet Director Recognitions & Rankings of Rendis Pharma India
Contact details
Rendis Pharma India Private Limited's registered office is in Mohali, Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressSinghpura Road Near Parsuram Mandir Kurali, Mohali, Punjab, India – 140103
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Rendis Pharma India Private Limited, buy the company report.
Comprehensive company report
Rendis Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rendis Pharma India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rendis Pharma India Private Limited, buy the company report.
Financials of Rendis Pharma India Private Limited
FY 2025 filings availableRendis Pharma India Private Limited reported revenue of ₹83.51 Lakh (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹83.51 Lakh ▲ 7%
Net profit · FY 2024
₹1.35 Lakh margin 1.6%
EBITDA · FY 2024
₹2.98 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 15%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 23% over three years, including 7% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rendis Pharma India Private Limited, buy the company report.
Board of directors of Rendis Pharma India Private Limited
Rendis Pharma India has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjit Singh | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
| Kamaljeet | Director | 11 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Rendis Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| American Impex Private Limited | ₹83.57 Lakh (FY 2024) | -43.0% | Chennai, Tamil Nadu, India | |||
| I T H Hydraulics Private Limited. | ₹83.57 Lakh (FY 2024) | 22.0% | New Delhi, Delhi, India | |||
| Tecsoe Commercial Private Limited | ₹83.55 Lakh (FY 2024) | 24.0% | Kolkata, West Bengal, India | |||
| Black Pearl Healthcare Private Limited | ₹83.54 Lakh (FY 2025) | 2.0% | Pune, Maharashtra, India | |||
| Shivshiva Technologies Private Limited | ₹83.53 Lakh (FY 2020) | -42.0% | Rohtak, Haryana, India | |||
| Rendis Pharma India Private Limitedthis company | ₹83.51 Lakh (FY 2024) | ₹1.35 Lakh | 1.6% | 7.0% | Mohali, Punjab, India | |
| Digvijay Cotsyn Private Limited | ₹83.51 Lakh (FY 2025) | -21.0% | Kolkata, West Bengal, India | |||
| Creditsnap India Private Limited | ₹83.49 Lakh (FY 2024) | 106.0% | Bengaluru, Karnataka, India | |||
| Sunshine Commosales Private Limited | ₹83.48 Lakh (FY 2024) | 170.0% | Kolkata, West Bengal, India | |||
| Sehwin Healthcare Private Limited | ₹83.48 Lakh (FY 2025) | 19.0% | Ambala Cantt, Haryana, India | |||
| MC Girl's India Private Limited | ₹83.47 Lakh (FY 2024) | 49.0% | Delhi, India |
To see the full peer comparison of Rendis Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rendis Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rendis Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rendis Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAICR8814Q1ZS | Punjab | Active | 04 Jun 2018 |
To see the full GST registrations and return filing status of Rendis Pharma India Private Limited, buy the company report.
Recent activity
Rendis Pharma India Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Kamaljeet was appointed as Director on 11 Apr 2018.
AGM
Rendis Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rendis Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Kamaljeet was appointed as Director.
Appointed
Ranjit Singh was appointed as Director.
Incorporation
11 Apr 2018
Rendis Pharma India Private Limited was registered on 11 Apr 2018 with Roc Chandigarh & aged 8 years 6 months as per MCA records.
Frequently asked questions
Rendis Pharma India is an active private limited company based in Mohali, Punjab, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 11 April 2018 (8+ years old) and is registered under CIN U24304PB2018PTC047738.
Rendis Pharma India has 2 current directors:
- Ranjit Singh - Director
- Kamaljeet - Director
The latest financial statements of Rendis Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rendis Pharma India is 03AAICR8814Q1ZS, registered in Punjab.
The CIN (Corporate Identification Number) of Rendis Pharma India is U24304PB2018PTC047738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rendis Pharma India was incorporated on 11 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Rendis Pharma India by revenue are American Impex Private Limited, I T H Hydraulics Private Limited, Tecsoe Commercial Private Limited, Black Pearl Healthcare Private Limited, Shivshiva Technologies Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kamaljeet was appointed as Director on 11 Apr 2018. Ranjit Singh was appointed as Director on 11 Apr 2018.
Yes, Rendis Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0031057).
The registered office of Rendis Pharma India is at Singhpura Road Near Parsuram Mandir Kurali, Mohali, Punjab, India – 140103.
Rendis Pharma India operates in the food and beverages industry, in the artificial fibres segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages